Insider · CIK 0002018966
Shannon Campbell
Files at BDTX (Black Diamond Therapeutics, Inc.), ZNTL (Zentalis Pharmaceuticals, Inc.). First filing -, latest -.
In brief
Shannon Campbell files SEC Form 4 as director at BDTX (Black Diamond Therapeutics, Inc.), and also at ZNTL (Zentalis Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Shannon Campbell has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 26, 2026 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jun 29, 2026 |
| May 26, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | AGrant or award Common Stock | +114,200 | $0.00 | $0 | 114,200 | May 27, 2026 |
| Jun 12, 2025 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,550 | $0.00 | $0 | 30,550 | Jun 12, 2025 |
| Dec 13, 2024 | BDTX Black Diamond Therapeutics, Inc. | AGrant or award Common Stock | +4,500 | $2.50 | $11k | 8,865 | Dec 16, 2024 |
Questions about Shannon Campbell
Answered from the filings on this page, as of the latest one.
Is Shannon Campbell buying or selling?
Shannon Campbell has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Shannon Campbell's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Shannon Campbell has 0.
Where does Shannon Campbell file Form 4?
Shannon Campbell has filed Form 4 at BDTX (Black Diamond Therapeutics, Inc.); ZNTL (Zentalis Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.